Stocks and InvestingStocks and Investing
Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024

Emily Bodnar Reiterated (ACRV) at Strong Buy and Held Target at $22 on, Sep 16th, 2024


Published on 2024-10-28 14:16:22 - WOPRAI, Emily Bodnar
  Print publication without navigation


Emily Bodnar of HC Wainwright & Co., Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $22 on, Sep 16th, 2024.

Emily, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30